Bromocriptine, a Dopamine (D2 ) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub–Therapeutic Doses to Ameliorate Hyperglycaemia
Introduction: Bromocriptine, an ergot derivative, is an agonist at the dopamine 2 receptor and a sympatholytic. It is a well established drug in Parkinsonism, hyperprolactinaemia and acromegaly and it has various other clinical indications like induction of ovulation in female infertility. Bromo...
Main Authors: | Harish Kumar V.S., Vinutha M.B., Pradeep A.N., Sathisha Aithal, Sindhura Reddy Baleed, Umakant N. Patil |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2013-09-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/3347/21-%205803_E(C)_F(T)_PF1(Pr._P)_PFA(P.r_P)pdf.pdf |
Similar Items
-
Mechanism of interaction of hypoglycemic agents glimepiride and glipizide with human serum albumin
by: Seedher Neelam, et al.
Published: (2009-03-01) -
Evaluation of physicochemical properties and in-vitro release profile of glipizide-matrix patch
by: Kajal Ghosal, et al.
Published: (2010-06-01) -
Formulation and evaluation of glipizide floating-bioadhesive tablets
by: Jayvadan K. Patel, et al.
Published: (2010-10-01) -
Effect of cholestasis on Bromocriptine-induced yawning
by: Parviz M, et al.
Published: (1998-08-01) -
Evaluation of commercial arrowroot starch/CMC film for buccal drug delivery of glipizide
by: Dhanasekaran Gayathri, et al.
Published: (2020-04-01)